Victory Capital Management’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$120K Buy
27,882
+319
+1% +$1.78K ﹤0.01% 2259
2025
Q4
$247K Buy
27,563
+1,044
+4% +$6.47K ﹤0.01% 2154
2025
Q3
$98.1K Sell
26,519
-520
-2% -$1.42K ﹤0.01% 2296
2025
Q2
$52.7K Sell
27,039
-315
-1% -$656 ﹤0.01% 2376
2025
Q1
$48.1K Sell
27,354
-985
-3% -$2.24K ﹤0.01% 2369
2024
Q4
$75.4K Buy
28,339
+7,441
+36% +$19.2K ﹤0.01% 2356
2024
Q3
$47.9K Sell
20,898
-297
-1% -$906 ﹤0.01% 2395
2024
Q2
$61.9K Buy
21,195
+2,349
+12% +$7.17K ﹤0.01% 2346
2024
Q1
$68.6K Sell
18,846
-528
-3% -$1.01K ﹤0.01% 2349
2023
Q4
$29.3K Buy
19,374
+3,494
+22% +$4.5K ﹤0.01% 2481
2023
Q3
$21.3K Buy
15,880
+408
+3% +$679 ﹤0.01% 2444
2023
Q2
$27.9K Sell
15,472
-361
-2% -$614 ﹤0.01% 2431
2023
Q1
$26.3K Buy
15,833
+300
+2% +$608 ﹤0.01% 2491
2022
Q4
$29.8K Sell
15,533
-7
-0% -$14 ﹤0.01% 2491
2022
Q3
$35K Buy
+15,540
New +$44.4K ﹤0.01% 2591
2022
Q1
Sell
-179,245
Closed -$1.52M 2789
2021
Q4
$1.52M Sell
179,245
-21,860
-11% -$201K ﹤0.01% 1652
2021
Q3
$2M Sell
201,105
-1,580
-0.8% -$14.3K ﹤0.01% 1606
2021
Q2
$1.89M Hold
202,685
﹤0.01% 1651
2021
Q1
$2.12M Buy
+202,685
New +$2.27M ﹤0.01% 1637

Other funds holding NUVB

Victory Capital Management's NUVB Position: Q1 2026 in Review

Victory Capital Management increased its Nuvation Bio (NUVB) stake by 1.2% in Q1 2026, buying an estimated $1.78K and bringing the position to 27,882 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2259.

Victory Capital Management first reported a position in NUVB in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.12M in Q1 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Victory Capital Management held 27,882 shares of Nuvation Bio worth $120K as of Q1 2026.
  • Victory Capital Management bought 319 Nuvation Bio shares in Q1 2026, an estimated $1.78K.
  • Nuvation Bio made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2259 holding.
  • Victory Capital Management first reported a position in Nuvation Bio in Q1 2021 and has held it in 19 quarters since.
  • Victory Capital Management's Nuvation Bio position peaked at $2.12M in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.